HRSA unveils 340B rebates 2.0
The 340B Drug Discount Program rebate demonstration applies to medicines that represented less than 5.5% of 340B sales in 2025.
Useful signal?
Sign in with GitHub below to react 👍 / 👎, or comment if a category looks wrong — your reactions help curate this feed. How feedback works